You may have heard about Progressive supranuclear palsy (PSP) in the...see more news lately, as a result of Reverand Jesse Jackson’s recent announcement about having the disease.  You may also be aware that in 2017, Rev. Jackson announced that he was diagnosed with Parkinson’s disease (PD). It turns […]

Read More

The longest government shutdown in United States history ended late Wednesday, November 12, with the passage of a continuing...see more resolution (CR) that reopens the federal government and extends funding through January 2026. The signed bill includes key elements that increase the government’s commitment to supporting Veterans and others with Parkinson’s disease (PD): The passage of […]

Read More

Take action today (Tuesday, September 9) and join...see more APDA and thousands of policy advocates across the country today as we urge elected officials to support key policies that will help expand and advance important progress for PD. Led by the Unified Parkinson’s Advocacy Council […]

Read More

A new study, partially funded by APDA, has found that exposure to a common pesticide can leave long-term changes...see more in the brain’s genetic landscape, possibly increasing the risk of Parkinson’s disease (PD). The research, published in Nature’s npj Parkinson’s Disease journal in July 2025, shows that the pesticide rotenone triggers lasting alterations in brain gene […]

Read More

An exciting development is underway as a new RNA-based blood test could help diagnose Parkinson’s disease (PD) prior to...see more the development of motor symptoms. The work, published in Nature Aging, demonstrated a way to target and detect specific sequences contained within transfer RNA (tRNA) for early diagnosis in a simple blood test. This approach will […]

Read More

Today in an exciting collaborative effort, three major Parkinson’s disease (PD) advocacy organizations have joined forces to issue a...see more public statement imploring lawmakers to robustly fund the National Institutes of Health (NIH) in the upcoming federal budget in order to keep Parkinson’s disease (PD) research moving forward as quickly as possible. This important joint statement […]

Read More

A recent study in Journal of the American Medical Association...see more has caused a stir, showing that living near golf courses is associated with an increased risk of Parkinson’s disease (PD). The study demonstrated that those living within a mile of a golf course had a 2.25 times increased […]

Read More

In exciting news, the FDA approved Medtronic’s deep brain stimulation (DBS) system known...see more as BrainSense™. Unlike standard DBS, which delivers electricity to the brain at pre-programmed settings, this technology can sense the brain’s electric signals, known as local field potentials or LFPs, and adjust the stimulation accordingly. This capability, […]

Read More

ONAPGOTM: A Newly-Approved Medication for OFF Periods in Parkinson’s Breaking News! The first subcutaneous (under the skin) apomorphine infusion,...see more now called ONAPGOTM, was approved by the Food and Drug Administration (FDA) on February 4, 2025. Apomorphine is a dopamine agonist whose effects have a rapid onset. It has been available in the US as a […]

Read More